Search results for "Coronavirus"
Adding P2Y12 inhibitor to heparin offered no benefit in non-critically ill COVID-19 inpatients
An open-label randomized trial at 60 hospitals in four countries found no increase in organ support-free days in patients who received a therapeutic dose of heparin plus a P2Y12 inhibitor versus heparin alone.
https://acphospitalist.acponline.org/archives/2022/01/19/adding-P2Y12-inhibitor-to-heparin-offered-no-benefit.htm
19 Jan 2022
Convalescent plasma did not facilitate recovery in COVID-19 inpatients, trial finds
There was a suggestion of benefit from plasma in patients treated earlier in the pandemic, before remdesivir and corticosteroids became the standard of care, according to exploratory analyses of this multicenter study.
https://acphospitalist.acponline.org/weekly/archives/2021/12/15/2.htm
15 Dec 2021
Monitoring outpatients by text appeared to reduce mortality from COVID-19
Patients with SARS-CoV-2 who received twice-daily, automated text message check-ins with an option to report worsening symptoms at any time had lower 30- and 60-day mortality than outpatients receiving usual care, a retrospective study found.
https://acphospitalist.acponline.org/weekly/archives/2021/11/17/4.htm
17 Nov 2021
NIH guidelines on anticoagulation in COVID-19; research on statin use, omicron variant
The NIH updated its guidelines to address anticoagulation in COVID-19 inpatients, treatment with atorvastatin did not appear to improve outcomes in the ICU, and several studies looked at characteristics of omicron.
https://acphospitalist.acponline.org/archives/2022/01/12/nih-guidelines-on-anticoagulation-research-on-statins-and-COVID-19.htm
12 Jan 2022
New info, resources on novel coronavirus disease (COVID-19)
ACP is offering an updated online learning activity and a podcast to help physicians learn about coronavirus. CME credit is free for members upon completion of either activity.
https://acphospitalist.acponline.org/weekly/archives/2020/03/04/1.htm
4 Mar 2020
January 19, 2022
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2022/01/19/
Heparin dosing for COVID-19 inpatients, expert perspectives on boosters
Two new trials offered some support for therapeutic anticoagulation in inpatients with elevated d-dimer levels. Antithrombotic therapy didn't prove helpful for outpatients with COVID-19. FDA advisors, an ACP/Annals forum, and recent research addressed vaccine effectiveness and boosters.
https://acphospitalist.acponline.org/weekly/archives/2021/10/20/1.htm
20 Oct 2021
COVID-19 guideline update from NIH, postdischarge anticoagulation, remdesivir effects
The latest news on inpatient COVID-19 care includes some changes to the NIH guidelines for COVID-19 treatment, as well as studies showing that rivaroxaban after discharge reduced clots and remdesivir helped inpatients on no or low-flow oxygen but not those who were sicker.
https://acphospitalist.acponline.org/weekly/archives/2021/12/22/1.htm
22 Dec 2021
Do you need a checklist?
There's limited evidence but apparent potential for these tools in hospital medicine.
https://acphospitalist.acponline.org/archives/2021/02/do-you-need-a-checklist.htm
15 Feb 2021
Early case reports show older men with comorbidities at highest risk for novel coronavirus
Two recent studies described the first diagnosed cases of the virus, while the World Health Organization declared a public health emergency and tallied the number affected worldwide.
https://acphospitalist.acponline.org/weekly/archives/2020/02/05/1.htm
5 Feb 2020